Enlivex (ENLV) has released an update.
Enlivex Therapeutics Ltd has announced its Annual General Meeting for shareholders to be held on October 31, 2024, with key agendas including board elections, option extensions, share unit grants, and amendments to executive service agreements. Shareholders as of September 16, 2024, will review the company’s financial statements and vote on proposals, which the Board recommends approving. The company emphasizes the importance of shareholder votes, whether in person or by proxy, with detailed voting instructions provided.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.
